Molecular Mechanisms and Therapies of Colorectal Cancer

Molecular Mechanisms and Therapies of Colorectal Cancer PDF Author: Donatella Delle Cave
Publisher:
ISBN: 9783036565460
Category : Rectum
Languages : en
Pages : 0

Get Book

Book Description

Molecular Mechanisms and Therapies of Colorectal Cancer

Molecular Mechanisms and Therapies of Colorectal Cancer PDF Author: Donatella Delle Cave
Publisher:
ISBN: 9783036565460
Category : Rectum
Languages : en
Pages : 0

Get Book

Book Description


Molecular Mechanisms and Therapies of Colorectal Cancer 2.0

Molecular Mechanisms and Therapies of Colorectal Cancer 2.0 PDF Author: Donatella Delle Cave
Publisher:
ISBN: 9783725809516
Category : Medical
Languages : en
Pages : 0

Get Book

Book Description
Colorectal cancer (CRC) is currently the third leading cause of cancer-related mortality. Transforming growth factor beta (TGF-β) signaling has been associated with CRC growth and metastasis due to its involvement in proliferation, epithelial-to-mesenchymal transition (EMT), and angiogenesis. The TGF-β superfamily contains over forty members, including TGF-βs, Nodal, Activin, and bone morphogenetic proteins (BMPs). Three types of TGF-β receptors (TGFβRs) have been identified: types 1, 2, and 3. After ligand binding, TGF-βR2 recruits and phosphorylates TGF-βR1, which, in turn, phosphorylates downstream SMAD (small mother against decapentaplegic) proteins. Phosphorylated SMAD4 translocates into the nucleus, where it activates the transcription of numerous target genes (including SERPINE1, LTBP2, CDKN1A, ARID3B, ATXN1, PTPRK, RAB6A, SMAD7, EHBP1, etc.), acting predominantly as a tumor suppressor gene. Interestingly, alterations in SMAD4 are frequent in metastatic CRC and, together with TGF-βR2 gene mutations, have been reported as late events able to promote CRC progression. The study of the TGF-β pathway in metastatic CRC is challenging because of the great genetic heterogeneity of CRC. However, the increasing availability of targeted and whole-exome DNA sequencing techniques makes it possible to identify genetic mutations in complex, dynamic, and heterogeneous clinical contexts and make correlations with clinical outcomes.

Molecular Mechanisms and Targeted Therapies for Colorectal Cancer

Molecular Mechanisms and Targeted Therapies for Colorectal Cancer PDF Author: Shilpa S. Dhar
Publisher: Frontiers Media SA
ISBN: 2832506410
Category : Medical
Languages : en
Pages : 201

Get Book

Book Description


Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies

Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies PDF Author: Chi Hin Cho
Publisher: Academic Press
ISBN: 0128199385
Category : Science
Languages : en
Pages : 242

Get Book

Book Description
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal cancer, along with the most up-to-date therapeutic strategies available. The book discusses reasons why colorectal tumors become refractory during the progression of the disease, but also explains how drug resistance occurs during chemotherapy. In addition, users will find the current therapeutic strategies used by clinicians in their practice in treating colorectal cancer. The combination of conventional anticancer drugs with chemotherapy-sensitizing agents plays a pivotal role in improving the outcome of colorectal cancer patients, in particular those with drug-resistant cancer cells. From a clinical point-of-view, the content of this book provides clinicians with updated therapeutic strategies for a better choice of drugs for drug-resistant colorectal cancer patients. It will be a valuable source for cancer researchers, oncologists and several members of biomedical field who are dedicated to better treat patients with colorectal cancer. Presents a systemic summary of molecular mechanisms for a quick and in-depth understanding Updates current trends in the field with pioneering information on drug resistance Encompasses both basic and clinical approaches for a better understanding of unsolved problems from a holistic point-of-view

Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment

Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment PDF Author: Ruowen Zhang
Publisher: Frontiers Media SA
ISBN: 2889743977
Category : Medical
Languages : en
Pages : 512

Get Book

Book Description


Molecular Biology of The Cell

Molecular Biology of The Cell PDF Author: Bruce Alberts
Publisher:
ISBN: 9780815332183
Category : Cytology
Languages : en
Pages : 0

Get Book

Book Description


Molecular Mechanisms of Cancer

Molecular Mechanisms of Cancer PDF Author: Georg F. Weber
Publisher: Springer Science & Business Media
ISBN: 1402060165
Category : Medical
Languages : en
Pages : 643

Get Book

Book Description
This book describes molecular processes whose deregulation is important in the formation of tumors. The material is developed from basic cell signaling pathways to their roles in the clinical manifestation of specific cancers. Topics covered include molecular events intrinsic to tumor cells (leading to growth deregulation, extended lifespan, and the ability to invade surrounding tissue), protective mechanisms that prevent transformation (including DNA repair and epigenetic regulation), tumor-host interactions (with the endocrine system, the immune system, and blood vessel formation), and the underlying molecular defects of individual cancers.

Colon Cancer Prevention

Colon Cancer Prevention PDF Author: American Institute for Cancer Resea
Publisher: Springer Science & Business Media
ISBN: 1461541492
Category : Medical
Languages : en
Pages : 169

Get Book

Book Description
The Eighth Annual Research Conference of the American Institute for Cancer Research, held in Washington, D.C., September 3-4, 1998, was on the subject "Colon Cancer Prevention: Dietary Modulation of Cellular and Molecular Mechanisms," with participants representing various disciplines interested in this area. One of the speak ers provided an appropriate quote from 17th century physician Thomas Adams: "Pre vention is better than healing because it saves the labor of being sick," which aptly describes the need for the prevention of cancer. An overview of normal and abnormal colonic development emphasized that although the typical human colon undergoes 1013 cell divisions by age 60, with the asso ciated possibilities for error, relatively few colon tumors develop. Since dietary modu lation leads to extremely small changes in colonic cells over a long period, animal models are useful to time, observe, and delineate the events associated with colon cancer. In the development colon cancer, the inactivation of the adenomatous polyposis coli (Apc) gene is one of the earliest known events. Normally Apc downregulates the cellular protein beta-catenin, but this is lost during cancer development. Beta-catenin may itself be an oncogene; it has a short half-life, but it is stabilized by binding to is more prevalent in the cell nucleus, the gene shuttles caherin. Although the Apc between the nucleus and the cytoplasm.

Colorectal Cancer

Colorectal Cancer PDF Author: Jim Cassidy
Publisher: CRC Press
ISBN: 142001630X
Category : Health & Fitness
Languages : en
Pages : 370

Get Book

Book Description
Written by world authorities on the subject, this reference comprehensively covers every aspect of colorectal cancer. Addressing the molecular mechanisms, genetics, identification, and therapy of disease, this guide covers new pharmaceutical developments, current screening protocols, and modern methods of disease management by specialists at renown

Molecular Pathogenesis of Colorectal Cancer

Molecular Pathogenesis of Colorectal Cancer PDF Author: Kevin M. Haigis, Ph.D.
Publisher: Springer Science & Business Media
ISBN: 146148412X
Category : Medical
Languages : en
Pages : 319

Get Book

Book Description
Colorectal cancer has for more than two decades served as the paradigm for the multi-step concept of cancer initiation and progression. Perhaps more than any other organ site, cancer of the colon is extensively characterized at the molecular level. We are now entering a time when molecular classification, rather than histologic classification, of cancer subtypes is driving the development of clinical trials with emerging targeted therapies. The book will focus on the progression from the identification of mutations that drive colorectal cancer initiation and progression to the search for novel therapies to treat the disease.